<DOC>
	<DOCNO>NCT00547846</DOCNO>
	<brief_summary>The pharmacological effect PDC-748 test numerous vitro vivo study . The exist pharmacologic finding suggest PDC-748 posse certain inhibitory activity citric acid- capsaicin-induced cough reflex guinea pig dose-dependent manner . Furthermore , previous Phase I/II uncontrolled , dose-escalating study show PDC-748 well tolerate may help alleviate daytime cough dose-responding manner.Hence , PhytoHealth Corporation intend carry Phase II investigation confirm preliminary finding use placebo comparator group , investigate PDC-748 dose escalate manner establish dose-response range antitussive effect , possible , determine maximal tolerable dose PDC-748 . This randomized , double-blind , placebo-controlled , dose escalate study evaluate safety efficacy escalate dose level PDC-748 patient acute cough .</brief_summary>
	<brief_title>A Phase II Clinical Study PDC-748 Patients With Acute Cough</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<criteria>Patients diagnose acute cough ; Men woman age â‰¥ 20 year old ; Patients Cough Symptom Score ( daytime ) 2 4 , inclusively ; Patients willing able comply study procedure sign inform consent . Patients chronic cough ; Patients chronic airway disease ; Patients respiratory tract malignancy ; Patients clinically suspect low respiratory tract infection ; Patients abnormal liver kidney function Patients take antitussive , sleep pill , sedative medication , herbal product ; Pregnant breastfeeding patient ; female patient child bear potential agree practice effective birth control ; Patient 's symptom acute cough may due heart failure may induce medication ACE inhibitor medication , determine investigator ; Patients history evidence medical condition would expose undue risk significant adverse event interfere assessment safety efficacy course trial , include limited hepatic , renal , respiratory , cardiovascular , endocrine , immune , neurological , hematological disease determine clinical judgment investigator ; Use investigational drug participation clinical trial within 28 day prior study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Cough</keyword>
	<keyword>Antitussive</keyword>
	<keyword>PDC-748</keyword>
	<keyword>PhytoHealth</keyword>
</DOC>